Abstract
Cancer is one of the killer diseases in humans and needs alternate curative measures despite recent improvement in modern treatment modalities. Oncolytic virotherapy seems to be a promising nonconventional way to treat cancers. Newcastle disease virus (NDV), a poultry virus, is nonpathogenic to human and domestic animals and has a long history of being used in oncotherapy research in several preclinical studies. The ability of NDV to successfully infect and destroy cancer cells is dependent on the strain and the pathotype of the virus. Adaptation of viruses to heterologous hosts without losing its replicative and oncolytic potential is prerequisite for use as cancer virotherapeutics. In the present study, velogenic NDV was adapted for replication in HeLa cells, and its cytotoxic potential was evaluated by observing morphological, biochemical, and nuclear landmarks of apoptosis. Our results indicated that the NDV-induced apoptosis in HeLa cells was dependent on upregulation of TNF-related apoptosis-inducing ligand (TRAIL) and caspases activation. Different determinants of apoptosis evaluated in the present study indicated that this strain could be a promising candidate for cancer therapy in future.
Similar content being viewed by others
References
Dey, M., Ulasov, I. V., & Lesniak, M. S. (2010). Cancer Letters, 289, 1–10.
Lazar, I., Yaacov, B., Shiloach, T., Eliahoo, E., Kadouri, L., Lotem, M., et al. (2010). Journal of Virology, 84(1), 639–646.
Zemp, F. J., Corredor, J. C., Lun, X., Muruve, D. A., & Forsyth, P. A. (2010). Cytokine Growth F. R, 21, 103–117.
Mayo, M. A. (2002). Archives of Virology, 147(8), 1655–1656.
Alexander, D. J. (1997). In diseases of poultry, 10th ed. (B. W. Calnek (ed.),), Iowa State University Press, Iowa, pp. 541-569.
Schirrmacher, V., Griesbach, A., & Ahlert, T. (2001). International Journal of Oncology, 18, 945–952.
Freeman, A. I., Zakay-Rones, Z., Gomori, J. M., Linetsky, E., Rasooly, L., Greenbaum, E., et al. (2006). Molecular Therapy, 13, 221–228.
Cassel, W. A., & Garret, R. E. (1965). Cancer, 18, 863–868.
Cassel, W. A., & Murray, D. R. (1992). Medicine Oncology Tumor Pharmacy, 9(4), 169–171.
Pecora, A. L., Rizvi, N., Cohen, G. I., Meropol, N. J., Sterman, D., Marshall, J. L., et al. (2002). Journal of Clinical Oncology, 20, 2251–2266.
Steiner, H. H., Bonsanto, M. M., Beckhove, P., Brysch, M., Geletneky, K., Ahmadi, R., et al. (2004). Journal of Clinical Oncology, 22(21), 4272–4281.
Csatary, L. K., Moss, R. W., Beuth, J., Torocsik, B., Szeberenyi, J., & Bakacs, T. (1999). Anticancer Research, 19, 635–638.
Csatary, L. K., Gosztonyi, G., Szeberenyi, J., Fabian, Z., Liszka, V., Bodey, B., et al. (2004). Journal of Neuro-Oncology, 67, 83–93.
Lorence, R. M., Pecora, A. L., Major, P. P., Hotte, S. J., Laurie, S. A., Roberts, M. S., et al. (2003). Current Opinion in Molecular Therapeutics, 5, 618–624.
Lorence, R. M., Roberts, M. S., O'Neil, J. D., Groene, W. S., Miller, J. A., Mueller, S. N., et al. (2007). Current Cancer Drug Targets, 7, 157–167.
Ali, R., Alabsi, A. M., Ali, A. M., Ainideris, Omar, A. R., & Khatijah, Y. (2011). International Journal of Cancer Research, 7(1), 25–35.
Liang, W., Wang, H., Sun, T. M., Yao, W. Q., Chen, L. L., Jin, Y., et al. (2003). World Journal of Gastroenterology, 9(3), 495–498.
Csatary, L. K., Eckhardt, S., Bukosza, I., Czegledi, F., Fenyvesi, C., Gergely, P., et al. (1993). Cancer Detection and Prevention, 17, 619–627.
Hotte, J. S., Lorence, R. M., Hirte, H. W., Polawski, S. R., Bamat, M. K., O'Neil, J. D., et al. (2007). Clinical Cancer Research, 13(3), 977–985.
Omar, A. R., Ali, A. I. A. M., Othman, F., Yusoff, K., Abdullah, J. M., Wali, H. S. M., et al. (2003). Malaysian Journal of Medical Sciences, 10(1), 4–12.
Reichard, K. W., Lorence, R. M., Cascino, C. J., Peeples, M. E., Walter, R. J., Fernando, M. B., et al. (1992). Journal of Surgical Research, 52, 448–453.
Bar-Eli, N., Giloh, H., Schlesinger, M., & Zakay-Rones, Z. (1996). Journal of Cancer Research and Clinical Oncology, 122, 409–415.
Yaacov, B., Eliahoo, E., Lazar, I., Ben-Shlomo, M., Greenbaum, I., Panet, A., et al. (2008). Cancer Gene Therapy, 15, 795–807.
Krishnamurthy, S., Takimoto, T., Scroggs, R. A., & Portner, A. (2006). Journal of Virology, 80, 5145–5155.
Mansour, M., Palese, P., & Zamarin, D. (2011). Journal of Virology, 84(12), 6015–6023.
Nykky, J., Tuusa, J. E., Kirjavainen, S., Vuento, M., & Gilbert, L. (2010). International Journal of Nanomedicine, 5, 417–428.
Nanthakumar, T., Kataria, R. S., Tiwari, A. K., Butchiah, G., & Kataria, J. M. (2000). Veterinary Research Communications, 24, 275–286.
Kalali, B. N., Kollisch, G., Mages, J., Muller, T., Bauer, T., Wagner, H., et al. (2008). Journal of Immunology, 181, 2694–2704.
Schmittgen, T. D., & Livak, K. J. (2008). Nature Protocols, 3(6), 1101–1108.
Available from www.oie.int/fileadmin/Home/eng/2.03.14, Accessed June 20, 2011.
Kenis, H., Genterbern, H. V., Rinia, H. A., Narula, T., & Hafstra, L. (2004). Journal of Biological Chemistry, 279, 52623–52629.
Hughes, D. and Mehmet H. (2003). Cell proliferation and apoptosis, 1st edn., (pp.341-342), BIOS Scientific, Oxford.
Blau, H. M., Chiu, C. P., & Webster, C. (1983). Cell, 32(4), 1171–1180.
Herrmann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W., & Kalde, J. R. (1994). Nucleic Acids Research, 22(24), 5506–5507.
Ravindra, P. V., Tiwari, A. K., Ratta, B., Chaturvedi, U., Palia, S. K., & Chauhan, R. S. (2009). Virus Research, 141, 13–20.
Vigil, A., Park, M. S., Martinez, O., Chua, M. A., Xiao, S., Cros, J. F., et al. (2007). Cancer Research, 67(17), 8285–8292.
Ahlert, T., & Schirrmacher, V. (1990). Cancer Research, 50(18), 5962–5968.
Zorn, U., Dallman, I., Grosse, J., Kirchner, H., Poliwoda, H., & Atzpodien, J. (1994). Cancer Biotherapy, 9, 225–235.
Washburn, B., & Schirrmacher, V. (2002). International Journal of Oncology, 21, 85–93.
Fabian, Z., Csatary, C. M., Szeberenyi, J., & Csatary, L. K. (2007). Journal of Virology, 81, 2817–2830.
Ahamed, T., Hossain, K. M., Billah, M. M., Islam, K. M. D., Ahasan, M. M., & Islam, M. E. (2004). International Journal of Poultry Science, 3(2), 153–156.
Ravindra, P. V., Ratta, B., Chaturvedi, U., Palia, S. K., Subudhi, P. K., & Tiwari, A. K. (2008). Journal of Hellenic Veterinarian Medical Society, 59(4), 341–345.
Mendy, M. E., Kaye, S., Sande, M. V., Rayco-Solon, P., Waight, P. A., Shipton, D., et al. (2006). Virology Journal, 3, 23.
Lay, M. L. J., Lucas, R. M., Ratnamohan, M., Taylor, J., & Ponsonby, A. L. (2010). Virology Journal, 7, 252.
Li, G., Li, W., Guoc, F., Xuc, S., Zhaod, N., Chena, S., et al. (2010). Journal of Virological Methods, 165, 9–14.
Katsates, V., Petsa, A., Felesakis, A., Paparidis, Z., Nikolaidou, E., Gargani, S., et al. (2009). Laboratory Medicine, 40(9), 557–560.
Fink, S. L., & Cookson, B. T. (2005). Infection and Immunity, 73(4), 1907–1916.
Kroemer, G., Zamzami, N., & Susin, S. A. (1997). Immunology Today, 18, 44–51.
Krysko, D. V., Berghe, V., D'Herde, K., & Vandenabeele, P. (2008). Methods, 44(3), 205–221.
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutelingperger, C. (1995). Journal of Immunological Methods, 184, 39–51.
Mo, H., & Elson, C. E. (1999). Journal of Nutrition, 129, 804–813.
Kraupp, B. G., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., & Schulte-Hermann, R. (1995). Hepatology, 21(5), 1465–1468.
Heatwole V. M. (1999) In: Methods in molecular biology, vol. 115 III (Javois, L. C. ed.) Humana Press Inc. Totowa, NJ, pp. 141-148.
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972). British Journal of Cancer, 26, 239–257.
Couderc, T., Guivel-Benhassine, F., Calaora, V., Gosselin, A. S., & Blondel, B. (2002). Journal of General Virology, 83, 1925–1930.
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J. L., Petit, P. X., et al. (1995). The Journal of Experimental Medicine, 181, 1661–1672.
Muhlenbeck, F., Haas, E., Schwenzer, R., Schubert, G., Grell, M., Smith, C., et al. (1998). Journal of Biological Chemistry, 273(49), 33091–33098.
Washburn, W., Weigand, M. A., Grosse-Wilde, A., Janke, M., Stahl, H., Riser, E., et al. (2003). Journal of Immunology, 170, 1814–1821.
Litz, J., Carlson, P., Warshamana-Greene, S. G., Grant, S., & Krystal, G. W. (2003). Clinical Cancer Research, 9, 4586–4594.
Acknowledgments
We are thankful to the director, Indian Veterinary Research Institute, Izatnagar for providing necessary facilities and the Department of Science and Technology (DST), Government of India for funding (Grant no. SR/SO/AS-0062/2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, R., Tiwari, A.K., Chaturvedi, U. et al. Velogenic Newcastle Disease Virus as an Oncolytic Virotherapeutics: In Vitro Characterization. Appl Biochem Biotechnol 167, 2005–2022 (2012). https://doi.org/10.1007/s12010-012-9700-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-9700-1